This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oneness Biotech Co.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Wei-Tse Tsai: Innovator in Bioactive Compounds
Introduction
Wei-Tse Tsai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of bioactive compounds, particularly in the context of cancer treatment. His innovative work focuses on the purification of compounds derived from mycelium and their application in medical therapies.
Latest Patents
Wei-Tse Tsai holds 1 patent related to bioactive compounds. The invention pertains to a method for treating various types of cancers, including liver cancer, brain cancer, prostate cancer, breast cancer, colorectal cancer, and melanoma. The compounds involved in this treatment are selected from a specific group, including AC006, AC007, AC009, AC011, AC012, AC007-H1, AC009-H1, and AC012-H1.
Career Highlights
Throughout his career, Wei-Tse Tsai has been associated with Oneness Biotech Co., where he has been instrumental in advancing research and development in the field of biotechnology. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Some of his notable coworkers include Chiung-Lin Liu and Kai-Hsin Hsieh, who have collaborated with him on various projects within the company.
Conclusion
Wei-Tse Tsai's innovative contributions to the field of bioactive compounds highlight his commitment to advancing cancer treatment methodologies. His work continues to inspire future research in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile